The Annexure

News to 16 October 2026 ·

Desk›Healthcare› Bajaj Healthcare Ltd

Bajaj Healthcare Ltd

BSE 539872 · NSE BAJAJHCARE · ISIN INE411U01027 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹322.10

+0.19%

BSE close, 28 August 2026

Market cap

₹1,084.27 cr

3.4 cr shares · Micro cap

Free float

₹411.34 cr

as published

P/E · P/B

61.5× · 2.43×

EPS ₹5.24 · BV ₹132.55

FY25-26 rev / PAT

611.03 / 15.77

₹ cr, as filed

Filings, window

14

2 selected · 14%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹272.45 52-WK HIGH ₹516.20 ₹322.10 20% of range
Against 52-week high-37.6%
Against 52-week low+18.2%
Day change+0.19%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹5.24
Price / earnings61.47×
Price / book2.43×
Book value — derived, price ÷ P/B₹132.55
Return on equity3.95%
Operating margin17.85%
Net margin8.27%

Consistency check

P/B ÷ P/E, which must equal ROE
3.95%
ROE as published
3.95%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 165.63 13.70 4.13 17.85% 8.27%
Mar-26 · Q 153.06 -22.85 -6.08 -4.97% -14.93%
FY25-26 611.03 15.77 6.73 12.88% 2.58%

Quarter on quarter

Revenue, quarter on quarter
+8.2%
Net profit, quarter on quarter
+160.0%
Operating margin, quarter on quarter
+2,282 bps

Disclosure profile 14 filings in the window

0 median 17.0 p75 · 24 sector max 59 14 39th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 24 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Concall Transcript1
Credit Rating1
Selected sub-total2
Procedural
General3
AGM / EGM2
Analyst / Investor Meet1
Board Meeting1
Compliance Certificate1
ESOP Allotment1
Newspaper Publication1
Record Date1
Trading Window1
Procedural sub-total12
Total14

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 98 trading days

14 filings · 2 selected · busiest 2026-10-09 and 2026-10-14

Filing rhythm · the twelve most recent

2026-08-122026-10-14

SelectedProcedural

Filings

14 in the window · 17 earlier on record

  1. 14 October 2026 ·

    General

    Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

    Receipt of Hon'ble NCLT Order approving acquisition of Genrx Pharmaceuticals Private Limited on a going concern basis

    Company Update / General View filing →

  2. 14 October 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Earning Call Invite

    Company Update / Analyst / Investor Meet View filing →

  3. 12 October 2026 ·

    General

    Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

    Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for the sale of a business unit of the Company

    Company Update / General View filing →

  4. 9 October 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration Of Financial Results

    Bajaj Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve the un-audited financial results ....

    Board Meeting / Board Meeting View filing →

  5. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 23 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation for closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 22 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Submission of Voting Results and Scrutinizer's Report

    AGM/EGM / AGM View filing →

  8. 21 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of the 33rd Annual General Meeting of the Company held on September 21, 2026

    AGM/EGM / AGM View filing →

  9. 3 September 2026 ·

    Record Date

    Corporate Action-Record Date For Payment Of Final Dividend

    Intimation of Record Date for the payment of Final Dividend for the financial year 2025-26

    Corp. Action / Record Date View filing →

  10. 26 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Intimation for Newspaper Publication with respect to 33rd Annual General Meeting of the Company

    Company Update / Newspaper Publication View filing →

  11. 21 August 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Intimation of allotment of equity shares pursuant to exercise of ESOPs

    Company Update / Allotment of ESOP / ESPS View filing →

  12. 12 August 2026 ·

    General

    Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015

    The Company has received the approval from DCGI to manufacture and market Cenobamate API and Tablets

    Company Update / General View filing →

  13. 6 August 2026 ·

    Credit Rating

    Credit Rating

    Revision in Credit Rating

    Company Update / Credit Rating View filing →

  14. 27 July 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of Earnings Call for Q1FY27

    Company Update / Earnings Call Transcript View filing →

RSS feed for Bajaj Healthcare Ltd · the 50 most recent filings